-
Startup Wants To Put A Stock Trader In Your Pocket, Aims To Become The Household Name For Algorithmic Trading
DISCLAIMER: During the interview for this story, the creators of PeakBot graciously offered to provide a discount to NewsBreak readers for trying out their services. The author has not received compensation for this article. While a promo code is included at the end of this story, it should not be considered promotional content but rather for informational purposes only. Previously published to NewsBreak. Putting a stock trader in your pocket, one company aims to become the household name for algorithmic trading — compliant with known United States Securities and Exchange Commission (S.E.C.) regulations and available to a wide range of retail investors across the United States. Regardless of trading experience, PeakBot works…
-
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …
You May Also Like
Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?
NASA-Approved Technologies Essential to Creating Cooler, Lighter and Safer Batteries for EV, Aeronautics and Smart Device Technologies
Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2
-
Digital Transformation Of Emerging Markets Could Mean Continued Opportunity For Newly NASDAQ Listed Japanese Company
Previously published on Benzinga HeartCore Enterprises Inc. (NASDAQ: HTCR) is a software-as-a-service (SaaS) solutions provider and leading development company in the enterprise business sector. In February, the company was uplisted to the Nasdaq Stock Exchange and rang the opening bell. Last June, Founder and CEO Sumitaka Kanno was honored with the Top 100 Tech Innovators & Influencers Award at InterCon Las Vegas for his significant and tangible contributions to the world of technology. HeartCore already held the largest market share in Japan for six straight years. It All Started With A Vision Founded in 2009, HeartCore (formerly XyXon Inc.) entered the market with its cornerstone HeartCore CMS rich content management…
-
Automating The Future Of Cannabis: How One Enterprise Wants To Lead The Charge Towards Large Scale Manufacturing
Previously Published On Benzinga A new operation in Commerce, California is quickly becoming one of the world’s largest next-generation cannabis production facilities. The 170,000 square-foot facility is owned and operated by the 4Front Ventures Corp. (OTCQX: FFNTF), a national, vertically-integrated multistate operator with seed-to-sale operations in strategic medical and adult-use cannabis markets, including Illinois, Massachusetts, Michigan, Washington and now, California. Established in 2011, 4Front Ventures has built a reputation in the industry for setting high standards in low-cost cultivation and applying traditional production methodologies to a less-than-traditional business sector. To date, the company has successfully brought more than 20 different cannabis brands and nearly 1,800 unique products to market. As the cannabis industry is…
You May Also Like
Alcatel-Lucent Successfully Completes First Stage of Polish Maritime Safety Initiative
Lineage, Pioneering a New Branch of Medicine — OpRegen Continues to Show Promising Results in Dry AMD with Geographic Atrophy
3D Eye Solutions by 3D Entertainment Holdings, Inc.: One company that gets it!
-
Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships
Previously Published to Benzinga It’s a new year, and 2022 may just become the Year of the Meta with virtual reality (VR), augmented reality (AR), and extended reality (XR) around every corner. Vuzix Corp. (NASDAQ: VUZI) is arguably no exception, leaving 2021 with a bang and entering the new year fresh-faced and making moves. The company is a leading supplier of smart glasses and AR technologies, developing innovative products primarily focused on enterprise markets. This includes personal displays and wearable computing devices triggered by touchpad, voice, and Bluetooth inputs. In addition, it offers users a portable, high-quality viewing experience, shared view video streaming, and dynamic solutions for mobility purposes. That means…
